CareLit · DOI-Nachweis · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Environmental risk assessment for medicinal products containing genetically modified organisms
DOI 10.1007/s00103-009-0986-2
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAnliker, B.; Longhurst, S.; Buchholz, C.
ZeitschriftBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Ausgabe11/2009
Jahrgang / SeitenJg. 52 · S. 52 bis 57
Kernaussage aus der Literatur
Abstract-Vorschau
Many gene therapy medicinal products and also some vaccines consist of, or contain, genetically modified organisms (GMOs), which require specific consideration in the environmental risk assessment (ERA) before marketing authorisation or clinical trial applications. The ERA is performed in order to identify the potential risks for public health and the environment, which may arise due to the clinical use of these med…
Zitieren
Zitierempfehlung
Anliker, B.; Longhurst, S.; Buchholz, C (2009) Environmental risk assessment for medicinal products containing genetically modified organisms. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 52 (11), 52 bis 57. https://doi.org/10.1007/s00103-009-0986-2
Mit CareLit weiterarbeiten